IFFO1 and ovarian cancer: In another study on the tumour suppressor IFFO1, researchers found that the METTL3/YTHDF2 axis regulates the mRNA stability of IFFO1 in an m6A-dependent manner, which inhibits metastasis and reverses drug resistance in ovarian cancer cells [137].